VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
🌟Lazy Sunday Lung Cancer Quiz No 5⃣:
What was the most frequent post-progression regimen after chemo+Amivantamab in MARIPOSA-2?
#some #LCSM @OncoAlert @HeSMO_X @OncoViews
@MedscapeOnc @OncologyTimes @oncologytube @EGFRmNSCLC
Oncology Conference Videos
Oncology News
At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
Al-Ola Abdallah, MD, Associate Professor of Medicine at The University of Kansas, conducted a study…
Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study…
By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…
By. Kellogg Parsons, MD Date: 12/07/2023 Kellogg Parsons, MD, a medical doctor and Vice President of…
Amidst the atmosphere of SABCS 2023, and at the center was Yara Abdou, MD, a…
Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…